Cargando…
A randomized clinical trial of unfractioned heparin for treatment of sepsis (the HETRASE study): design and rationale [NCT00100308]
INTRODUCTION: Infection promotes coagulation via a large number of molecular and cellular mechanisms, and this procoagulant activity has boosted basic and clinical research using anticoagulant molecules as therapeutic tools in sepsis. Heparin, which is a naturally occurring proteoglycan that acts by...
Autores principales: | Jaimes, Fabián, De La Rosa, Gisela, Arango, Clara, Fortich, Fernando, Morales, Carlos, Aguirre, Daniel, Patiño, Pablo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482716/ https://www.ncbi.nlm.nih.gov/pubmed/16729879 http://dx.doi.org/10.1186/1745-6215-7-19 |
Ejemplares similares
-
Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database
por: Peng, Jiang-Chen, et al.
Publicado: (2022) -
Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients
por: Gratz, Johannes, et al.
Publicado: (2020) -
The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?
por: Belen-Apak, F.B., et al.
Publicado: (2020) -
A latent class approach for sepsis diagnosis supports use of procalcitonin in the emergency room for diagnosis of severe sepsis
por: Jaimes, Fabián A, et al.
Publicado: (2013) -
Toward an operative diagnosis in sepsis: a latent class approach
por: De La Rosa, Gisela D, et al.
Publicado: (2008)